You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCVIDDOXIL Regimen

Showing 1 - 25 of 8,980
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in Houston (Cyclophosphamide, Mesna, Vincristine)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 2, 2020

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)

Not yet recruiting
  • Pulmonary Tuberculosis
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
  • +37 more
Oct 11, 2023

Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

Not yet recruiting
  • Refractory
  • +2 more
  • GTP regimen
  • (no location specified)
Sep 8, 2023

Glaucoma Trial in San Francisco (App)

Not yet recruiting
  • Glaucoma
  • App
  • San Francisco, California
    San Francisco General Hospital
Sep 13, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • Best-Available Therapy(BAT) Regimen
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 10, 2023

Tuberculosis, Pulmonary Trial (Optimised dose rifampicin, Standard dose rifampicin)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Optimised dose rifampicin
  • Standard dose rifampicin
  • (no location specified)
Sep 26, 2023

Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)

Recruiting
  • Locally Advanced Colorectal Carcinoma
  • Beijing, Beijing, China
    Cancer Hospital/ National Cancer Center, Chinese Academy of Medi
Nov 23, 2023

Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)

Recruiting
  • Gastric Cancer
  • +2 more
  • Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 1, 2023

Eribulin-Based Regimen Versus Other Chemotherpy in

Active, not recruiting
  • Breast Cancer
  • Eribulin-Based Regimen
  • +2 more
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Jul 18, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Refractory Leukemia Trial in Shanghai (CALGE-VEN- RIC-MBF)

Recruiting
  • Refractory Leukemia
  • CALGE-VEN- RIC-MBF
  • Shanghai, Shanghai, China
  • +2 more
May 22, 2023

Pharmacokinetics, Bioavailability Trial in Nottingham (Sorafenib - Period 1, XS005 Sorafenib Capsule A - Period 1, XS005

Completed
  • Pharmacokinetics
  • Bioavailability
  • Sorafenib - Period 1
  • +8 more
  • Nottingham, United Kingdom
    Quotient Sciences
Jul 20, 2023

Diabetic Macular Edema Trial (Faricimab)

Not yet recruiting
  • Diabetic Macular Edema
  • (no location specified)
Jan 20, 2023

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

Obesity, Nausea and Vomiting, Postoperative Trial in Mexico City (Aprepitant, Placebo)

Active, not recruiting
  • Obesity
  • Nausea and Vomiting, Postoperative
  • Mexico City, Mexico
    Hospital General Tlahuac
Mar 6, 2023

Waldenström's Macroglobulinemia Trial (zanubrutinib,bendamustine,rituximab)

Not yet recruiting
  • Waldenström's Macroglobulinemia
  • (no location specified)
Aug 4, 2023

Surufatinib Plus Sintilimab Combined With Chemotherapy in

Recruiting
  • Gastric Neuroendocrine Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 22, 2023

Breast Cancer Trial in Pittsburgh (Nutrition and resistance training exercise intervention)

Recruiting
  • Breast Cancer
  • Nutrition and resistance training exercise intervention
  • Pittsburgh, Pennsylvania
    AHN CI Exercise Oncology and Resiliency
Jul 31, 2023

Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

Recruiting
  • Acute Leukemia
  • mitoxantrone liposome
  • ATG
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Feb 13, 2023

Amyotrophic Lateral Sclerosis Trial (DNL343, Matching Placebo)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Apr 24, 2023

Pain, Postoperative, Tonsillar Hypertrophy, Tonsillitis Trial in Saint Louis (Alternating Acetaminophen and Ibuprofen, Combined

Completed
  • Pain, Postoperative
  • +2 more
  • Alternating Acetaminophen and Ibuprofen
  • Combined Acetaminophen and Ibuprofen
  • Saint Louis, Missouri
    Saint Louis Children's Hospital
Jan 26, 2023

Colorectal Carcinoma Trial (Fruquintinib?Capecitabine Tablets)

Not yet recruiting
  • Colorectal Carcinoma
  • Fruquintinib、Capecitabine Tablets
  • (no location specified)
Oct 30, 2023

Nasopharyngeal Carcinoma, Maintenance Therapy Trial in Guangzhou (Capecitabine/Placebo combined with treprizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Maintenance Therapy
  • Capecitabine/Placebo combined with treprizumab
  • Guangzhou, Guangdong, China
    SunYat-senU
May 11, 2023

Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

Recruiting
  • Lymphoma
  • BEAM Protocol
  • CEM protocol
  • Cairo, Egypt
    International Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023